Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Specialized Vascular Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Specialized Vascular Technologies

Specialized Vascular Technologies

Acquired

Specialized Vascular Technologies: Enhancing safety and efficacy of drug eluting stents since 2007.

HQ
Fremont, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees

Specialized Vascular Technologies, Inc. develops technologies to improve the safety and efficacy of drug eluting stent.

The company was incorporated in 2007 and is based in Fremont, California.

Specialized Vascular Technologies - Similar Companies

Traverse Vascular logo

Traverse Vascular

Novostent logo

Novostent

Attwill Vascular Technologies logo

Attwill Vascular Technologies

Cross Vascular logo

Cross Vascular

Vascular Dynamics logo

Vascular Dynamics

Vascular Imaging logo

Vascular Imaging

eLum Technologies logo

eLum Technologies

Svelte Medical Systems logo

Svelte Medical Systems

Clear Vascular logo

Clear Vascular

Vascular Designs logo

Vascular Designs

Scientia Vascular logo

Scientia Vascular

TheraVasc logo

TheraVasc

Evident Vascular logo

Evident Vascular

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Vascular Therapies logo

Vascular Therapies

vasculartx.com

Specialized Vascular Technologies - Quick Facts

Who are Specialized Vascular Technologies' competitors?

Companies similar to Specialized Vascular Technologies include Traverse Vascular, Novostent, Attwill Vascular Technologies and Cross Vascular.

When was Specialized Vascular Technologies founded?

Specialized Vascular Technologies was founded in 2007.

Where is Specialized Vascular Technologies' headquarters located?

Specialized Vascular Technologies' headquarters is located in Fremont, CA, US.

When was Specialized Vascular Technologies' last funding round?

Specialized Vascular Technologies' most recent funding round was for $90.2k (USD) in September 2010.

How much has Specialized Vascular Technologies raised to-date?

As of Sep 2, 2010, Specialized Vascular Technologies has raised a total of $90.2k (USD).

Specialized Vascular Technologies - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research